Trans Ox Citations Result in Warning Letter (June 8, 2015) During a November 13, 2014, through November 20, 2014, inspection of Trans Ox pharmaceutical manufacturing facility at 2543 Morningside Drive, Suite A, West Columbia, South Carolina, an investigator from the U.S. Food and Drug Administration (FDA) identified significant violations of current good manufacturing … [Read more...]